Dapagliflozin, a sodium glucose cotransporter 2 inhibitors, protects cardiovascular function in type-2 diabetic murine model
Crossref DOI link: https://doi.org/10.1007/s12041-020-01196-9
Published Online: 2020-05-29
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Saleh, Sohair
Hanna, Gergess
El-Nabi, Sobhy Hassab
El-domiaty, Heba
Shabaan, Anwaar
Ewida, Suzy Fayez
Text and Data Mining valid from 2020-05-29
Version of Record valid from 2020-05-29
Article History
Received: 10 December 2019
Revised: 6 February 2020
Accepted: 17 February 2020
First Online: 29 May 2020